Abstract
Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is rapidly being adopted in the medical community as an adjunctive therapeutic tool in the management of primary and secondary liver malignancies. Given the complexity of the treatment algorithm of patients who may be candidates for this therapy and the need for clinical guidance, a comprehensive review of the methodologic and technical considerations was undertaken. This experience is based on more than 900 Y infusions performed over a 5-year period.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1251-1278 |
| Number of pages | 28 |
| Journal | Journal of Vascular and Interventional Radiology |
| Volume | 17 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2006 |
Fingerprint
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Cite this
}
Radioembolization with 90yttrium microspheres : A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies - Part 1: Technical and methodologic considerations. / Salem, Riad; Thurston, Kenneth G.
In: Journal of Vascular and Interventional Radiology, Vol. 17, No. 8, 01.08.2006, p. 1251-1278.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Radioembolization with 90yttrium microspheres
T2 - A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies - Part 1: Technical and methodologic considerations
AU - Salem, Riad
AU - Thurston, Kenneth G.
PY - 2006/8/1
Y1 - 2006/8/1
N2 - Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is rapidly being adopted in the medical community as an adjunctive therapeutic tool in the management of primary and secondary liver malignancies. Given the complexity of the treatment algorithm of patients who may be candidates for this therapy and the need for clinical guidance, a comprehensive review of the methodologic and technical considerations was undertaken. This experience is based on more than 900 Y infusions performed over a 5-year period.
AB - Microsphere and particle technology represent the next-generation agents that have formed the basis of interventional oncology, an evolving subspecialty of interventional radiology. One of these platforms, yttrium-90 microspheres, is rapidly being adopted in the medical community as an adjunctive therapeutic tool in the management of primary and secondary liver malignancies. Given the complexity of the treatment algorithm of patients who may be candidates for this therapy and the need for clinical guidance, a comprehensive review of the methodologic and technical considerations was undertaken. This experience is based on more than 900 Y infusions performed over a 5-year period.
UR - http://www.scopus.com/inward/record.url?scp=33747515562&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747515562&partnerID=8YFLogxK
U2 - 10.1097/01.RVI.0000233785.75257.9A
DO - 10.1097/01.RVI.0000233785.75257.9A
M3 - Review article
C2 - 16923973
AN - SCOPUS:33747515562
VL - 17
SP - 1251
EP - 1278
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
SN - 1051-0443
IS - 8
ER -